Tang Capital Partners, 10% Owner: TCR2 Therapeutics TCRR Buy · Filed 23/05/10

Trade details

Type: Insider buy
Amount: $111,292.35
Shares · price: 57,073 sh · $1.95 a share
Held after: 4,272,937 sh
Stock: TCR2 Therapeutics TCRR
Person: Tang Capital Partners10% Owner
Trade date: 23/05/08
Filed: 23/05/10
Days to filing: 2 days

3 insiders bought this week

Insiders buying this week: 3 insiders
Holding change: +1.4%

TCR2 Therapeutics trades, last 26 weeks

What else happened in TCR2 Therapeutics around then

Filed or reported within 30 days of the trade day · 23/04/08~23/06/07

Tang Capital Partners's recent trades

Tang Capital Partners10% Owner
BuySingular Genomics Systems
Buy
Singular Genomics Systems
OMIC
$642.3K
50,416 sh
$642.3K
Filed 24/09/18
Traded 24/09/16
Tang Capital Partners10% Owner
BuySingular Genomics Systems
Buy
Singular Genomics Systems
OMIC
$613.2K
40,000 sh
$613.2K
Filed 24/09/18
Traded 24/09/17
Tang Capital Partners10% Owner
BuySingular Genomics Systems
Buy
Singular Genomics Systems
OMIC
$550.7K
32,000 sh
$550.7K
Filed 24/09/18
Traded 24/09/18
Tang Capital Partners10% Owner
SellRain Oncology
Sell
Rain Oncology
RAIN
$131.3K
109,435 sh
$131.3K
Filed 23/12/18
Traded 23/12/15
Tang Capital Partners10% Owner
SellRain Oncology
Sell
Rain Oncology
RAIN
$48.6K
40,132 sh
$48.6K
Filed 23/12/18
Traded 23/12/18

Tang Capital Partners, 10% Owner — bought $111.3K of TCR2 Therapeutics TCRR · 57,073 sh @ $1.95 | Whalegun